Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
April 30, 2002
Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG
motexafin gadolinium
RADIATION
radiation therapy
Trial Locations (1)
21231
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00032097 - Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain | Biotech Hunter | Biotech Hunter